Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70418-4 ◽

2007 ◽

Vol 2007 ◽

pp. 200-203

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Southwest Oncology Group ◽

Download Full-text

Faculty Opinions recommendation of Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3360961.3050062 ◽

2010 ◽

Author(s):

Nico van Zandwijk

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Early Stage ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Southwest Oncology Group ◽

Download Full-text

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2017.05.037 ◽

2017 ◽

Vol 83 ◽

pp. 302-312 ◽

Author(s):

David Ferry ◽

Lucinda Billingham ◽

Hugh Jarrett ◽

David Dunlop ◽

Penella J. Woll ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

A randomized phase III trial of the Southern Italy Oncology Group (G.O.I.M.). of mitomycin C plus vindesine and cisplatin (MVP regimen) versus vinorelbine plus cisplatin (PV regimen) in stage III–IV non small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(00)80063-x ◽

2000 ◽

Vol 29 (1) ◽

pp. 21 ◽

Author(s):

D Galetta ◽

V Gebbia ◽

F Riccardi ◽

N Borsellino ◽

C Gridelli ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Cell Lung Cancer ◽

Southern Italy ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: A phase III study of the Southwest Oncology Group

Lung Cancer ◽

10.1016/0169-5002(94)90869-9 ◽

1994 ◽

Vol 10 (5-6) ◽

pp. 421-422

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Southwest Oncology Group ◽

Phase Iii Study

Download Full-text

Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC) - final results of a British Thoracic Oncology Group (BTOG) trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7066 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7066-7066

Author(s):

P. Lorigan ◽

R. Booton ◽

L. Ashcroft ◽

K. O'Byrne ◽

H. Anderson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

A British Thoracic Oncology Group phase III trial of Gemcitabine plus Cisplatin at 80 mg/m^2 versus Gemcitabine plus Cisplatin at 50 mg/m^2 versus Gemcitabine plus Carboplatin area under the concentration-time curve (AUC) 6 in stage IIIB/IV non-small cell lung cancer (NSCLC)

http://isrctn.org/> ◽

10.1186/isrctn80153848 ◽

2012 ◽

Author(s):

David Ferry

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Concentration Time

Download Full-text

Randomized phase III study of docetaxel (D) versus vinorelbine (V) for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of a West Japan Thoracic Oncology Group trial (WJTOG9904)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7009 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7009-7009 ◽

Author(s):

K. Takeda ◽

S. Kudoh ◽

K. Nakagawa ◽

M. Takada ◽

N. Katakami ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

O-095 A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small cell lung cancer — A randomised multicentre trial of the British thoracic oncology group (BTOG1)

Lung Cancer ◽

10.1016/s0169-5002(05)80229-6 ◽

2005 ◽

Vol 49 ◽

pp. S34

Author(s):

P. Lorigan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Cell Lung Cancer ◽

Multicentre Trial ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

O-092 Randomized phase III study of docetaxel (D) versus vinorelbine (V) for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of a West Japan Thoracic Oncology Group trial (WJTOG9904)

Lung Cancer ◽

10.1016/s0169-5002(05)80226-0 ◽

2005 ◽

Vol 49 ◽

pp. S33 ◽

Author(s):

K. Tamura ◽

S. Kudoh ◽

S. Negoro ◽

K. Nakagawa ◽

M. Takada ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

Randomized phase III trial of the Southern Italy Oncology Group comparing sequential ifosfamide + gemcitabine followed by cisplatin + navelbine (IG -> PN) versus the opposite sequence (PN -> IG) versus cisplatin + navelbine (PN) versus gemcitabine + cisplatin (GP) in stage III–IV non small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(00)80084-7 ◽

2000 ◽

Vol 29 (1) ◽

pp. 27

Author(s):

V Gebbia ◽

D Galetta ◽

M Caruso ◽

N Borsellino ◽

F Varvara ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Southern Italy ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Opposite Sequence

Download Full-text